SCHEMBL13435198

SCHEMBL13435198

Cc1cccc(CC2(C)CCN([C@@H]3CC[C@]4(O)CC5CC4[C@H]3C5)C2=O)c1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13435197 0.84 HSD11B1 (0.39)
SCHEMBL13435196 0.82 HSD11B1 (0.35)
SCHEMBL3427038 0.77 HSD11B1 (0.45)
SCHEMBL5038669 0.75 OPRM1 (0.30)
SCHEMBL3426482 0.74 HSD11B1 (0.34)
SCHEMBL5662819 0.71 HSD11B1 (0.33)
SCHEMBL3427043 0.70
SCHEMBL3422925 0.62 HSD11B1 (0.66)
SCHEMBL14186140 0.61
SCHEMBL13435167 0.60 HSD11B1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687644-B2 Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors JANSSEN PHARMACEUTICA NV (BE) 2010-03-30 US disclosed
US-20070287743-A1 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2007-12-13 US disclosed
US-20070287743-A1 Adamantyl Pyrrolidin-2-One Derivatives as 11-Beta Hydroxtsteroid Dehydrogenase Inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 2007-12-13 US disclosed